AHB-137

DRUG7 trials

Sponsors

Ausper Biopharma Co., Ltd., AusperBio Therapeutics Inc.

Conditions

Chronic Hepatitis BHepatitis B, Chronic

Phase 2

Study to Evaluate the Efficacy and Safety of AHB-137 Injection in Participants With Chronic Hepatitis B (CHB).

Active, not recruitingNCT06550128

Ausper Biopharma Co., Ltd.Hepatitis B, Chronic

Start: 2024-07-10End: 2026-10-01Updated: 2026-05-07

Study to Evaluate the Efficacy and Safety of AHB-137 in Treatment-naive Participants With Chronic Hepatitis B (CHB)

Active, not recruitingNCT06829329

Ausper Biopharma Co., Ltd.Chronic Hepatitis B

Start: 2024-12-13End: 2026-12-01Updated: 2026-05-07

A Study to Evaluate the Antiviral Activity and Immune Response of AHB-137 Injection in Participants With Chronic Hepatitis B (CHB)

Active, not recruitingNCT06993480

Ausper Biopharma Co., Ltd.Chronic Hepatitis B

Start: 2025-07-15End: 2027-02-09Updated: 2026-05-04

A Multicenter Study of AHB-137 Injection Combined With Other Hepatitis B Drugs

RecruitingNCT07069569

Ausper Biopharma Co., Ltd.Chronic Hepatitis B

Start: 2025-06-08End: 2028-01-15Target: 200Updated: 2026-05-20

A Study to Evaluate the Efficacy and Safety of AHB-137 Injection in Participants With Chronic Hepatitis B (CHB)

RecruitingNCT07137910

Ausper Biopharma Co., Ltd.Chronic Hepatitis B

Start: 2025-09-04End: 2027-06-01Target: 60Updated: 2026-05-04

Phase 2 Study of AHB-137 in HBeAg Negative Chronic Hepatitis B (CHB) Participants in Asia Pacific Region

RecruitingNCT07370207

AusperBio Therapeutics Inc.Hepatitis B, Chronic

Start: 2026-03-06End: 2028-12-31Target: 84Updated: 2026-04-13

Phase 3

Study of AHB-137 in Participants With Chronic Hepatitis B (CHB) Treated With Nucleos(t)Ide Analogues (NAs)(AUSHINE)

Active, not recruitingNCT07246889

Ausper Biopharma Co., Ltd.Chronic Hepatitis B

Start: 2025-08-12End: 2027-10-31Updated: 2026-05-04